BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 78 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $1,434,000 | +36.4% | 33,096 | +46.5% | 0.38% | +35.5% |
Q3 2017 | $1,051,000 | +8.4% | 22,592 | +15.3% | 0.28% | +6.4% |
Q2 2017 | $970,000 | -9.7% | 19,592 | 0.0% | 0.26% | -0.7% |
Q1 2017 | $1,074,000 | -1.6% | 19,592 | 0.0% | 0.27% | +3.9% |
Q4 2016 | $1,091,000 | +21.9% | 19,592 | 0.0% | 0.26% | +24.2% |
Q3 2016 | $895,000 | +14.5% | 19,592 | 0.0% | 0.21% | +8.4% |
Q2 2016 | $782,000 | +97.0% | 19,592 | +72.0% | 0.19% | +76.9% |
Q1 2016 | $397,000 | -18.8% | 11,392 | 0.0% | 0.11% | -11.5% |
Q4 2015 | $489,000 | -17.5% | 11,392 | +6.5% | 0.12% | -22.8% |
Q3 2015 | $593,000 | -3.3% | 10,692 | +0.9% | 0.16% | -26.9% |
Q2 2015 | $613,000 | +19.7% | 10,592 | -19.0% | 0.22% | +8.0% |
Q1 2015 | $512,000 | +1.4% | 13,075 | -0.0% | 0.20% | -3.4% |
Q4 2014 | $505,000 | -1.2% | 13,076 | -9.7% | 0.21% | +3.0% |
Q3 2014 | $511,000 | +31.0% | 14,478 | +0.0% | 0.20% | +18.9% |
Q2 2014 | $390,000 | +4.0% | 14,475 | 0.0% | 0.17% | +11.2% |
Q1 2014 | $375,000 | – | 14,475 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 385,954 | $16,723,000 | 10.02% |
JW Asset Management, LLC | 73,649 | $3,191,000 | 3.40% |
Elk Creek Partners, LLC | 168,714 | $7,310,000 | 0.43% |
NORTHPOINTE CAPITAL LLC | 80,710 | $3,497,000 | 0.39% |
Ativo Capital Management LLC | 33,096 | $1,434,000 | 0.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 155,318 | $6,730,000 | 0.26% |
ISTHMUS PARTNERS, LLC | 17,406 | $754,000 | 0.20% |
Matarin Capital Management, LLC | 48,952 | $2,121,090,000 | 0.16% |
GLOBEFLEX CAPITAL L P | 4,324 | $187,000 | 0.05% |
Summit Trail Advisors, LLC | 6,797 | $295,000 | 0.04% |